Patents by Inventor Jungsuh P. Kim
Jungsuh P. Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6838556Abstract: This invention provides nucleic acid sequences, vectors and host cells comprising regulatory regions associated with various promoters including a cyclin D1 promoter, a CD40L promoter, three HBV promoters (core, pre-S1 and HBV-X), a vancomycin-resistant enterococci (VRE) promoter, an androgen receptor promoter, a Her2 promoter, and ?-lactamase promoter. The invention further provides methods of regulating gene expression comprising the regulatory regions of such promoters.Type: GrantFiled: June 6, 2001Date of Patent: January 4, 2005Assignee: Genelabs Technologies, Inc.Inventors: Jungsuh P. Kim, Douglas B. Starr, Albert W. Tam, Megan E. Laurance, Emil F. Michelotti, Mark D. Velligan, Derek R. Latour, Rita L. Thomas, Ana Kongpachith, Liana T. Sheppard, Moon Young Kim, Thomas W. Bruice
-
Publication number: 20030027320Abstract: This invention provides nucleic acid sequences, vectors and host cells comprising regulatory regions associated with various promoters including a cyclin D1 promoter, a CD40L promoter, three HBV promoters (core, pre-S1 and HBV-X), a vancomycin-resistant enterococci (VRE) promoter, an androgen receptor promoter, a Her2 promoter, and &bgr;-lactamase promoter. The invention further provides methods of regulating gene expression comprising the regulatory regions of such promoters.Type: ApplicationFiled: June 6, 2001Publication date: February 6, 2003Inventors: Jungsuh P. Kim, Douglas B. Starr, Albert W. Tam, Megan E. Laurance, Emil F. Michelotti, Mark D. Velligan, Derek R. Latour, Rita L. Thomas, Ana Kongpachith, Liana T. Sheppard, Moon Young Kim, Thomas W. Bruice
-
Patent number: 5874563Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals having a non-A, non-B, non-C, non-D, non-E Hepatitis, herein designated Hepatitis G Virus (HGV). Corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides are taught. The antigens are useful in diagnostic methods for detecting the presence of HGV in test subjects. The antigens are also useful in vaccine and antibody preparations. In addition, the entire coding sequences of two HGV isolates are disclosed. Methods are presented for nucleic acid-based detection of HGV in samples and also methods for the isolation of further genomic sequences corresponding to HGV.Type: GrantFiled: June 5, 1995Date of Patent: February 23, 1999Assignee: Genelabs Technologies, Inc.Inventors: Jungsuh P. Kim, Kirk E. Fry, Lavonne Marie Young, Jeffrey M. Linnen, John Wages
-
Patent number: 5859230Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals infected with non-A, non-B, non-C, non-D, non-E hepatitis. Also disclosed are corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides. The antigens are useful in diagnostic methods for detecting the presence of N-(ABCDE) hepatitis agent infection in primates. The antigens are also useful in vaccine and antibody preparations. Methods are presented for the isolation of entire genomes corresponding to the N-(ABCDE) hepatitis agents.Type: GrantFiled: March 6, 1996Date of Patent: January 12, 1999Assignee: Genelabs Technologies, Inc.Inventors: Jungsuh P. Kim, Gregory R. Reyes, LaVonne Marie Young
-
Patent number: 5856134Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals having a non-A, non-B, non-C, non-D, non-E Hepatitis, herein designated Hepatitis G Virus (HGV). Corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides are taught. The antigens are useful in diagnostic methods for detecting the presence of HGV in test subjects. The antigens are also useful in vaccine and antibody preparations. In addition, the entire coding sequences of two HGV isolates are disclosed. Methods are presented for nucleic acid-based detection of HGV in samples and also methods for the isolation of further genomic sequences corresponding to HGV.Type: GrantFiled: June 5, 1995Date of Patent: January 5, 1999Assignee: Genelabs Technologies, Inc.Inventors: Jungsuh P. Kim, Kirk E. Fry, LaVonne Marie Young, Jeffrey M. Linnen, John Wages
-
Patent number: 5849532Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals having a non-A, non-B, non-C, non-D, non-E Hepatitis, herein designated Hepatitis G Virus (HGV). Corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides are taught. The antigens are useful in diagnostic methods for detecting the presence of HGV in test subjects. The antigens are also useful in vaccine and antibody preparations. In addition, the entire coding sequences of two HGV isolates are disclosed. Methods are presented for nucleic acid-based detection of HGV in samples and also methods for the isolation of further genomic sequences corresponding to HGV.Type: GrantFiled: June 6, 1995Date of Patent: December 15, 1998Assignee: Genelabs Technologies, Inc.Inventors: Jungsuh P. Kim, Kirk E. Fry, LaVonne Marie Young, Jeffrey M. Linnen, John Wages
-
Patent number: 5843636Abstract: Peptide antigens which are immunoreactive with sera from individuals infected with hepatitis C virus (HCV) are disclosed. Several of the antigens are immunologically reactive with antibodies present in individuals identified as having chronic and acute HCV infection. The antigens are useful in diagnostic methods for detecting HCV infection in humans. Also disclosed are corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic peptides.Type: GrantFiled: March 17, 1995Date of Patent: December 1, 1998Assignee: Genelabs Technologies, Inc.Inventors: Gregory R. Reyes, Jungsuh P. Kim, Randolph Moeckli, Christian C. Simonsen
-
Patent number: 5843639Abstract: Peptide antigens which are immunoreactive with sera from individuals infected with hepatitis C virus (HCV) are disclosed. Several of the antigens are immunologically reactive with antibodies present in individuals identified as having chronic and acute HCV infection. The antigens are useful in diagnostic methods for detecting HCV infection in humans. Also disclosed are corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic peptides.Type: GrantFiled: June 7, 1995Date of Patent: December 1, 1998Assignee: Genelabs Technologies, Inc.Inventors: Gregory R. Reyes, Jungsuh P. Kim, Randolph Moeckli, Christian C. Simonsen
-
Patent number: 5824507Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals having a non-A, non-B, non-C, non-D, non-E Hepatitis, herein designated Hepatitis G Virus (HGV). Corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides are taught. The antigens are useful in diagnostic methods for detecting the presence of HGV in test subjects. The antigens are also useful in vaccine and antibody preparations. In addition, the entire coding sequences of two HGV isolates are disclosed. Methods are presented for nucleic acid-based detection of HGV in samples and also methods for the isolation of further genomic sequences corresponding to HGV.Type: GrantFiled: May 19, 1995Date of Patent: October 20, 1998Assignee: Genelabs Technologies, Inc.Inventors: Jungsuh P. Kim, Kirk E. Fry, LaVonne Marie Young, Jeffrey M. Linnen, John Wages
-
Patent number: 5766840Abstract: Polypeptide antigens are disclosed which are immunoreactive with sera from individuals having a non-A, non-B, non-C, non-D, non-E Hepatitis, herein designated Hepatitis G Virus (HGV). Corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides are taught. The antigens are useful in diagnostic methods for detecting the presence of HGV in test subjects. The antigens are also useful in vaccine and antibody preparations. In addition, the entire coding sequences of two HGV isolates are disclosed. Methods are presented for nucleic acid-based detection of HGV in samples and also methods for the isolation of further genomic sequences corresponding to HGV.Type: GrantFiled: June 5, 1995Date of Patent: June 16, 1998Assignee: Genelabs Technologies, Inc.Inventors: Jungsuh P. Kim, Kirk E. Fry, LaVonne Marie Young, Jeffrey M. Linnen, John Wages
-
Patent number: 5538865Abstract: Peptide antigens which are immunoreactive with sera from individuals infected with hepatitis C virus (HCV) are disclosed. Several of the antigens are immunologically reactive with antibodies present in individuals identified as having chronic and acute HCV infection. The antigens are useful in diagnostic methods for detecting HCV infection in humans. Also disclosed are corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic peptides.Type: GrantFiled: January 19, 1994Date of Patent: July 23, 1996Assignee: Genelabs Technologies, Inc.Inventors: Gregory Reyes, Jungsuh P. Kim, Randolph Moeckli
-
Patent number: 5443965Abstract: Peptide antigens which are immunoreactive with sera from individuals infected with hepatitis C virus (HCV) are disclosed. Several of the antigens are immunologically reactive with antibodies present in individuals identified as having chronic and acute HCV infection. The antigens are useful in diagnostic methods for detecting HCV infection in humans. Also disclosed are corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic peptides.Type: GrantFiled: April 5, 1991Date of Patent: August 22, 1995Assignee: Genelabs IncorporatedInventors: Gregory R. Reyes, Jungsuh P. Kim, Randolph Moeckli
-
Patent number: 5436318Abstract: Peptide antigens which are immunoreactive with sera from individuals infected with hepatitis C virus (HCV) are disclosed. Several of the antigens are immunologically reactive with antibodies present in individuals identified as having chronic and acute HCV infection. The antigens are useful in diagnostic methods for detecting HCV infection in humans. Also disclosed are corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic peptides.Type: GrantFiled: March 20, 1992Date of Patent: July 25, 1995Assignee: Genelabs Technologies, Inc.Inventors: Gregory Reyes, Jungsuh P. Kim, Randolph Moeckli